Previous Article | Next Article ![]()
Journal of Bacteriology, April 2007, p. 2677-2682, Vol. 189, No. 7
0021-9193/07/$08.00+0 doi:10.1128/JB.01762-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

State Key Laboratory of Microbial Resource, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100080, People's Republic of China,1 Chinese National Human Genome Center at Shanghai, Shanghai, 200031, People's Republic of China2
Received 18 November 2006/ Accepted 29 January 2007
|
|
|---|
-carbon and nitrogen atoms (of both 2-aminomuconate and 2-amino-5-chloromuconate) were simultaneously attacked by a hydroxyl group and a proton, respectively. Homologs of cnbZ were identified in the genomes of Bradyrhizobium japonicum, Rhodopseudomonas palustris, and Roseiflexus sp. strain RS-1; these genes were previously annotated as encoding hypothetical proteins of unknown function. It is concluded that CnbZ represents a novel enzyme that deaminates xenobiotic compounds and/or
-amino acids. |
|
|---|
Certain bacteria or microbial consortia can utilize 4-chloronitrobenzene (4-CNB) as the sole source of carbon and nitrogen (9, 14, 22). 2-Amino-5-chloromuconate is an intermediate in the 4-CNB degradation pathway of Comamonas sp. strain CNB-1 (21). cnbH occurs in the degradative cnb cluster and encodes 2-amino-5-chloromuconate deaminase (21). However, the specific activity of CnbH expressed in Escherichia coli is 7 nmol min1 (mg of cellular protein)1 (2-aminomuconate as the substrate) (21), an activity that would appear to be too inefficient for bacterial growth. Indeed, the deaminase activity of cellular lysates of Comamonas sp. strain CNB-1 approximates 2.5 µmol min1 (mg of cellular protein1) (2-aminomuconate as the substrate) (unpublished data). These contrasting observations indicate that Comamonas sp. strain CNB-1 might contain an alternative deaminase and prompted the present study.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Bacterial strains, plasmids, and primers used in this study
|
Determination of native molecular mass and N-terminal sequence. The native molecular mass of the deaminase was estimated by gel filtration chromatography with a Superdex 200 column (Amersham Biosciences) at a flow rate of 0.5 ml min1 with Tris-HCl (50 mM; pH 8.0)-NaCl (0.1 M) buffer. Carbonic anhydrase (29 kDa), albumin (66 kDa), alcohol dehydrogenase (150 kDa), ß-amylase (200 kDa), apoferritin (443 kDa), and thyroglobulin (669 kDa) (all from Sigma) were used as molecular mass standards.
To check the purity and determine the N-terminal sequence of 2-amino-5-chloromuconate deaminase, the FPLC-purified enzyme was subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (12% acrylamide). The resulting single protein band was transferred to a polyvinylidene difluoride membrane by electroblotting and visualized by Coomassie brilliant blue staining. The protein band was cut out and sequenced by the Edman degradation method using an Applied Biosystems Procise 491 protein sequencer.
Operation of Q-TOF-MS and peptide identification. For identification of the peptide fingerprint and obtaining more information on the sequence of the purified deaminase, the deaminase was subjected to digestion by trypsin. The tryptic peptides were separated on a Waters capillary liquid chromatography system. The system was coupled on-line with a quadrupole time-of-flight (Q-TOF) Ultima Global mass spectrometer (Waters), and the samples were directly eluted into a Q-TOF mass spectrometer at 250 nl min1 on the analytical column. A tandem mass spectrometry (MS/MS) data search was processed using Mass Lynx 4.0 and an online MS/MS ion-searching program.
Plasmid DNA extraction and sequencing. The plasmid pCNB1 was isolated from strain CNB-1 by using the modified alkaline lysis method (16). The plasmid DNA was sequenced using a shotgun method. A contig was obtained containing putative arsenate resistance genes and an open reading frame (ORF), named cnbZ, whose product had an N-terminal sequence identical to that of the purified deaminase.
Cloning, overexpression, and purification of the deaminase (CnbZ) in E. coli. PCR primers (Table 1) were designed according to the DNA sequence of cnbZ to amplify the entire 2-amino-5-chloromuconate deaminase gene (753 bp) from the plasmid pCNB1. The PCR product was purified, treated with NdeI and BamHI, and ligated into pET-28a(+) which had been digested with the same restriction enzymes. The resulting plasmid, designated pETcnbZ, was used to transform E. coli BL21(DE3). Synthesis of recombinant protein in E. coli BL21(DE3) cells was initiated by addition of 1 mM isopropyl 1-thio-ß-D-galactopyranoside (IPTG) when the culture reached an optical density at 600 nm of 0.6 to 0.8. Cultivation was continued for an additional 4 h after the addition of IPTG. Cells were harvested by centrifugation and broken by sonication as described above. Recombinant cnbZ-derived protein was purified with a His-Bind protein purification kit (Novagen, Madison, WI) according to the manufacturer's instructions.
Deaminase activity and extinction coefficient of 2-amino-5-chloromuconic acid.
2-Aminomuconate deaminase activity was determined as described by He and Spain (7). 2-Amino-5-chloromuconate deaminase activity was determined similarly, but A340, which is the maximum absorption of 2-amino-5-chloromuconate (21), was monitored. The extinction coefficient of 2-amino-5-chloromuconate was determined by adoption of the extinction coefficient of 2-hydroxy- 5-chloromuconate (
= 12,650 M1·cm1) (15) and of a complete enzymatic conversion of 2-amino-5-chloromuconate to 2-hydroxy-5-chloromuconate. The extinction coefficient of 2-amino-5-chloromuconate was 22,000 M1·cm1 based on the Beer-Lambert law.
RNA isolation and RT-PCR. For RNA isolation, Comamonas sp. strain CNB-1 was cultivated in 100 ml MSB containing 2 mM 4-CNB as the sole source of carbon and nitrogen. Total RNA was isolated using a TRIzol reagent kit (Tiangen, Beijing, China) according to the manufacturer's instruction. The extracted RNA was solved in 50 µl water. To eliminate any genomic DNA, this RNA preparation was incubated with 10 U DNase and 40 U of RNase inhibitor (Takara, catalog no. D2310A) for 30 min at 37°C. To obtain cDNAs, the above-described preparations (8 µl, containing 2 µg RNA) were mixed, respectively, with 4 µl of 10 µM primer CnbZrtPr for cnbZ or CnbHrtPr for cnbH (Table 1) in final volumes of 12 µl. To facilitate reverse transcription (RT), any RNA secondary structures were eliminated by incubation at 70°C for 5 min, and pairing between RNA templates and primers was stimulated by quickly placing the mixtures on ice. cDNAs were synthesized in a reaction mixture (total volume 21 µl) containing the above-prepared mixture (12 µl), 4 µl reaction buffer (Promega), 1 µl of 10 mM deoxynucleoside triphosphate, 1 µl RNase inhibitor, 2 µl of 0.5 mM MgCl2, and 1 µl ImProm-II reverse transcriptase (Promega). The mixtures were incubated for 60 min at 42°C, and reactions were terminated by incubation at 70°C for 15 min. The cDNAs synthesized were used for amplification of cnbZ or cnbH fragments with PCR. PCRs were carried out using Taq DNA polymerase (Promega) and the primers CnbZrtPf/CnbZrtPr for cnbZ and CnbHrtPf/CnbHrtPr for cnbH, respectively.
Protein determination and chemicals. Protein concentrations were determined by the Bradford method (3). Bovine serum albumin was used as a standard. 2-Amino-5-chloromuconate and 2-aminomuconate were enzymatically prepared as described by He and Spain (8) and Wu et al. (21). Other chemicals were purchased from Sigma or Fluka. All restriction enzymes, Taq and Pfu polymerases, and T4 DNA ligase were from Promega or Takara.
Alignment of proteins. Alignment of CnbZ and other related putative proteins from genomes of different bacterial species was carried out with CLUSTALW (18).
Nucleotide sequence accession number. The DNA sequence reported here is available at GenBank under accession number DQ875599.
|
|
|---|
|
View this table: [in a new window] |
TABLE 2. Purification of 2-amino-5-chloromuconate deaminase from Comamonas sp. strain CNB-1
|
Cloning of the 2-amino-5-chloromuconate deaminase gene. Before the plasmid pCNB1 was sequenced, various efforts to obtain the deaminase gene from genomic DNA were carried out with pairs of degenerate primers based on the N-terminal sequence and the six peptides but did not succeed. Meanwhile, it was found that a mutant of strain CNB-1, namely, strain CNB-2, which had lost plasmid pCNB1 (21), had also lost deaminase activity. This indicated that the deaminase gene was possibly located on plasmid pCNB1. As the pCNB1 sequence project was completed, examination of the sequence of pCNB1 revealed a contig flanked by two transposases (Fig. 1). In addition to the transposases, this contig contained a hypothetical protein that has an N-terminal sequence identical to that of the purified deaminase, as well as the previously identified six peptides, according to Q-TOF-MS. This putative gene (named cnbZ herein) was PCR amplified and cloned onto vector pET28a(+), resulting in pETcnbZ. E. coli BL21(DE3) cells harboring pETcnbZ showed high deaminase activity upon induction with 1 mM IPTG. This result clearly indicated that cnbZ encodes the previously purified deaminase.
![]() View larger version (21K): [in a new window] |
FIG. 1. Organization of the genetic fragment containing cnbZ and comparison to other genetic fragments that contain cnbZ homologs. The sequence upstream of cnbZ is shown; the predicted promoter consensus sequence is underlined, the transcription start codon is boxed, and the translational start codon is shown in italics. cnbZ and the putative arsenate resistance genes (arsRABC) are flanked by two putative transposase genes. Sequence identities of ArsC, ArsB, ArsA, and ArsR from Comamonas sp. strain CNB-1 to their counterparts from B. japonicum strain USDA 110 are 59%, 15%, 48%, and 37%, respectively. The sequence identities of Orf2 to Blr7786 and OrfJ are 44% and 41%, respectively; however, the C termini of Blr7786 and OrfJ were not found in Orf2. RBS, ribosome binding site.
|
|
View this table: [in a new window] |
TABLE 3. Annotation and identification of homologs of putative genes of the cnbZ genetic fragment from Comamonas sp. strain CNB-1
|
CnbZ has novel catalytic properties different from previously known deaminases of Pseudomonas species.
The 2-amino-5- chloromuconate deaminase used 2-amino-5-chloromuconate and 2-aminomuconate as substrates. Methyl-3-aminocrotonate and vinylglycine as well as saturated
-amino acids such as glutamic acid, glutamine, aspartic acid, and asparagines were not used as substrates (at concentrations of 50 and 100 µM). The Vmaxs of CnbZ for 2-amino-5-chloromuconate and 2-aminomuconate were 196 and 147 µmol·min1·mg1, respectively, and the Kms were 3.9 and 8.8 µM, respectively. These data indicated that CnbZ was more adapted for 2-amino-5-chloromuconate than 2-aminomuconate. Cysteine residue-modifying agents such as p-chloromercuribenzoate (0.2 mM) and the SH-binding metals (2 mM) Zn2+, Ni2+, and Cu2+ completely inhibited deaminase activity, whereas Ca2+, Mg2+, and the histidine residue-modifying agent diethyl pyrocarbonate (at 2 and 10 mM) inhibited the activity by 23 to 50%. EDTA (at 5 and 50 mM) and dithiothreitol (10 mM) did not exert observable effects on deaminase activity. Based on these results, it was deduced that an SH group(s) was probably involved in catalysis.
Typical spectral changes during CnbZ-catalyzed deamination of 2-aminomuconate and 2-amino-5-chloromuconate are shown in Fig. 2. Based on the observations that the maximal absorption of 2-hydroxy-5-chloromuconate occurs at 306 nm and that the maximal absorption of 2-oxopent-5-chloro-3-enoate occurs at 245 nm (15), the product of 2-amino-5-chloromuconate deamination was identified as 2-hydroxy-5-chloromuconate (Fig. 2A). Spontaneous isomerization of 2-hydroxy-5-chloromuconate into 2-oxal-5-chloromuconate did not happen, unless tautomerase CnbG (21) was added to the assay buffer (data not shown). It was found that 2-hydroxymuconate spontaneously isomerized into 4-oxalocrotonate, and the isomerization rates were almost equally high (3.2 nmol·min1 for spontaneous isomerization of 2-hydroxymuconate) as for 2-aminomuconate deamination (3.7 nmol·min1), as determined in this study. Therefore, it was concluded that the true product during 2-aminomuconate deamination catalyzed by CnbZ was most probably 2-hydroxymuconate, and this product spontaneously converted into its keto form, 2- oxalomuconate (Fig. 2B).
![]() View larger version (20K): [in a new window] |
FIG. 2. Typical spectral changes during deamination of 2-aminomuconate (A) and 2-amino-5-chloromuconate (B) by purified deaminase CnbZ and proposed catalytic mechanisms. Absorption was recorded every 30 s. The amount of purified CnbZ in the reaction was 2.7 µg of protein. Below the graphs is a proposed putative mechanism of CnbZ-catalyzed deamination, which includes simultaneous attacks on the -carbon and nitrogen atoms of 2-aminomuconate/2-amino-5-chloromuconate, respectively, by a hydroxyl group and a proton.
|
![]() View larger version (23K): [in a new window] |
FIG. 3. Analysis of cnbZ and cnbH transcription by RT-PCR. Templates used for PCR were as follows: lanes 1 and 4, cDNAs from total RNA preparation; lanes 2 and 5, total RNA preparation; lanes 3 and 6, total genomic DNA. Primers (CnbZrtPf and CnbZrtPr [Table 1]) specific for cnbZ were used for lanes 1, 2, and 3; primers (CnbHrtPf and CnbHrtPr [Table 1]) specific for cnbH were used for lanes 4, 5, and 6. Lane M, DNA markers; bands from top to bottom represent 2,500, 2,000, 1,000, 750, 500, and 250 bp.
|
|
|
|---|
![]() View larger version (15K): [in a new window] |
FIG. 4. Evolutionary dendrogram of deaminases involved in nitrobenzene and chloronitrobenzene degradation and homologs selected from results of a BLASTP search of GenBank, performed as described by Altschul et al. (1). The phylogenetic tree was generated using the neighbor-joining method with the Mega 3.1 software. *, the sequence was obtained from the SEED database (http://theseed.uchicago.edu/FIG/index.cgi). The scale at the bottom shows sequence divergence.
|
The true products from CnbZ-catalyzed deamination of 2-aminomuconate and 2-amino-5-chloromuconate were identified as 2-hydroxymuconate and 2-hydroxy-5-chloromuconate (enol form). This is different from previously characterized 2-aminomuconate deamination, which was catalyzed by deaminases from Pseudomonas pseudoalcaligenes JS45 (7), Pseudomonas putida HS12 (13), and P. putida AP-3 (17), of which the true deamination product of 2-aminomuconate was claimed to be 4-oxalocrotonate (oxo form). The formation of different products by CnbZ may reflect a different catalytic mechanism, and a putative hypothesis to illustrate the CnbZ-catalyzed deamination is proposed. Further work on crystallization and mutagenesis of CnbZ is in progress.
We are grateful to Harold L. Drake at the University of Bayreuth, Bayreuth, Germany, for editing the manuscript and for constructive suggestions.
Published ahead of print on 26 January 2007. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»